Caseware UK (AP4) 2023.0.135 2023.0.135 2024-09-30NI6779022024-09-30truetruetruetruetruetrue2023-10-01falseNo description of principal activity33true NI677902 2023-10-01 2024-09-30 NI677902 2022-10-01 2023-09-30 NI677902 2024-09-30 NI677902 2023-09-30 NI677902 2022-10-01 NI677902 c:Director1 2023-10-01 2024-09-30 NI677902 d:Buildings d:LongLeaseholdAssets 2023-10-01 2024-09-30 NI677902 d:Buildings d:LongLeaseholdAssets 2024-09-30 NI677902 d:Buildings d:LongLeaseholdAssets 2023-09-30 NI677902 d:FurnitureFittings 2023-10-01 2024-09-30 NI677902 d:FurnitureFittings 2024-09-30 NI677902 d:FurnitureFittings 2023-09-30 NI677902 d:FurnitureFittings d:OwnedOrFreeholdAssets 2023-10-01 2024-09-30 NI677902 d:ComputerEquipment 2023-10-01 2024-09-30 NI677902 d:ComputerEquipment 2024-09-30 NI677902 d:ComputerEquipment 2023-09-30 NI677902 d:ComputerEquipment d:OwnedOrFreeholdAssets 2023-10-01 2024-09-30 NI677902 d:OwnedOrFreeholdAssets 2023-10-01 2024-09-30 NI677902 d:CurrentFinancialInstruments 2024-09-30 NI677902 d:CurrentFinancialInstruments 2023-09-30 NI677902 d:CurrentFinancialInstruments d:WithinOneYear 2024-09-30 NI677902 d:CurrentFinancialInstruments d:WithinOneYear 2023-09-30 NI677902 d:ShareCapital 2024-09-30 NI677902 d:ShareCapital 2023-09-30 NI677902 d:RetainedEarningsAccumulatedLosses 2023-10-01 2024-09-30 NI677902 d:RetainedEarningsAccumulatedLosses 2024-09-30 NI677902 d:RetainedEarningsAccumulatedLosses 2023-09-30 NI677902 d:AcceleratedTaxDepreciationDeferredTax 2024-09-30 NI677902 d:AcceleratedTaxDepreciationDeferredTax 2023-09-30 NI677902 c:OrdinaryShareClass1 2023-10-01 2024-09-30 NI677902 c:OrdinaryShareClass1 2024-09-30 NI677902 c:OrdinaryShareClass1 2023-09-30 NI677902 c:FRS102 2023-10-01 2024-09-30 NI677902 c:Audited 2023-10-01 2024-09-30 NI677902 c:FullAccounts 2023-10-01 2024-09-30 NI677902 c:PrivateLimitedCompanyLtd 2023-10-01 2024-09-30 NI677902 d:WithinOneYear 2024-09-30 NI677902 d:WithinOneYear 2023-09-30 NI677902 d:BetweenOneFiveYears 2024-09-30 NI677902 d:BetweenOneFiveYears 2023-09-30 NI677902 c:SmallCompaniesRegimeForAccounts 2023-10-01 2024-09-30 NI677902 e:PoundSterling 2023-10-01 2024-09-30 xbrli:shares iso4217:GBP xbrli:pure



















My Health Digital Ltd

Registered number: NI677902
Information for filing with the Registrar
For the year ended 30 September 2024

 
 NI677902
30 September 2024
MY HEALTH DIGITAL LTD
REGISTERED NUMBER: NI677902

STATEMENT OF FINANCIAL POSITION
AS AT 30 SEPTEMBER 2024

2024
2023
Note
£
£

Fixed assets
  

Tangible assets
 5 
13,621
19,875

  
13,621
19,875

Current assets
  

Stocks
 6 
76,780
30,743

Debtors: amounts falling due within one year
 7 
70,252
35,622

Cash at bank and in hand
 8 
33,347
4,204

  
180,379
70,569

Creditors: amounts falling due within one year
 9 
(136,238)
(81,758)

Net current assets/(liabilities)
  
 
 
44,141
 
 
(11,189)

Total assets less current liabilities
  
57,762
8,686

Provisions for liabilities
  

Deferred tax
 10 
(334)
(1,748)

Net assets
  
57,428
6,938


Capital and reserves
  

Called up share capital 
 11 
200
200

Profit and loss account
 12 
57,228
6,738

  
57,428
6,938


The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of comprehensive income in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 9 April 2025.


J P O'Loan
Director

The notes on pages 2 to 12 form part of these financial statements.
- 1 -

 
 NI677902
30 September 2024
MY HEALTH DIGITAL LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2024

1.


General information

My Health Digital Ltd ('the Company') is a private company, limited by shares, incorporated and registered in the United Kingdom (Registered number: NI677902).
The address of the registered office is 3c Bluestone Business Park, Moyraverty West Road, Moyraverty, Craigavon, BT65 5HU.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Section 1A of Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

The preparation of financial statements in compliance with FRS 102 requires the use of certain critical accounting estimates. It also requires management to exercise judgment in applying the Company's accounting policies (see note 3).

These financial statements have been presented in pound sterling which is the functional currency of the Company, and rounded to the nearest £.

The following principal accounting policies have been applied:

 
2.2

Financial Reporting Standard 102 - reduced disclosure exemptions

The Company has taken advantage of the following disclosure exemptions in preparing these financial statements, as permitted by the FRS 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland":
the requirements of Section 7 Statement of Cash Flows;
the requirements of Section 3 Financial Statement Presentation paragraph 3.17(d);
the requirements of Section 11 Financial Instruments paragraphs 11.42, 11.44 to 11.45, 11.47, 11.48(a)(iii), 11.48(a)(iv), 11.48(b) and 11.48(c);
the requirements of Section 12 Other Financial Instruments paragraphs 12.26 to 12.27, 12.29(a), 12.29(b) and 12.29A;
the requirements of Section 33 Related Party Disclosures paragraph 33.7.

This information is included in the consolidated financial statements of JCCO Healthcare Limited as at 30 September 2024 and these financial statements may be obtained from 37 Greenhey Place, East Gillibrands, Skelmersdale, Lancashire, WN8 9SA.

- 2 -

 
 NI677902
30 September 2024
MY HEALTH DIGITAL LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2024

2.Accounting policies (continued)

 
2.3

Going concern

The directors have performed a review of the Company's financial projections and cash flows, considering macro-economic factors such as inflation and interest rates together with the wider going concern status of the Company. Operational performance and customer service levels have also remained very strong throughout this period. The directors have considered all possible outcomes of this review in the going concern assessment and conclude that the business would remain a going concern with sufficient funds in all possible scenarios.
The parent entity (JCCO Healthcare Limited) will provide support to make sufficient funds available if needed for at least twelve months from the date of the audit report.

 
2.4

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Sale of goods

Revenue from the sale of goods is recognised when all of the following conditions are satisfied:
the Company has transferred the significant risks and rewards of ownership to the buyer;
the Company retains neither continuing managerial involvement to the degree usually associated with ownership nor effective control over the goods sold;
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the transaction; and
the costs incurred or to be incurred in respect of the transaction can be measured reliably.

- 3 -

 
 NI677902
30 September 2024
MY HEALTH DIGITAL LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2024

2.Accounting policies (continued)

 
2.5

Current and deferred taxation

The tax expense for the year comprises current and deferred tax. Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the Company operates and generates income.

Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the reporting date, except that:
The recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits; and
Any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met.

Deferred tax balances are not recognised in respect of permanent differences except in respect of business combinations, when deferred tax is recognised on the differences between the fair values of assets acquired and the future tax deductions available for them and the differences between the fair values of liabilities acquired and the amount that will be assessed for tax. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the reporting date.

 
2.6

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

Depreciation is provided on the following basis:

L/Term Leasehold Property
-
20%
Fixtures & fittings
-
20%
Computer equipment
-
33%

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

- 4 -

 
 NI677902
30 September 2024
MY HEALTH DIGITAL LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2024

2.Accounting policies (continued)

 
2.7

Stocks

Stocks are stated at the lower of cost and net realisable value, being the estimated selling price less costs to complete and sell. Cost is based on the cost of purchase on a first in, first out basis. Work in progress and finished goods include labour and attributable overheads.

At each reporting date, stocks are assessed for impairment. If stock is impaired, the carrying amount is reduced to its selling price less costs to complete and sell. The impairment loss is recognised immediately in profit or loss.

 
2.8

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.9

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.10

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 
2.11

Provisions for liabilities

Provisions are recognised when an event has taken place that gives rise to a legal or constructive obligation, a transfer of economic benefits is probable and a reliable estimate can be made.
Provisions are measured as the best estimate of the amount required to settle the obligation, taking into account the related risks and uncertainties.
 
Increases in provisions are generally charged as an expense to profit or loss.

- 5 -

 
 NI677902
30 September 2024
MY HEALTH DIGITAL LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2024

2.Accounting policies (continued)

 
2.12

Financial instruments

The Company has elected to apply the provisions of Section 11 “Basic Financial Instruments” of FRS 102 to all of its financial instruments.

The Company has elected to apply the recognition and measurement provisions of IFRS 9 Financial Instruments (as adopted by the UK Endorsement Board) with the disclosure requirements of Sections 11 and 12 and the other presentation requirements of FRS 102.

Financial instruments are recognised in the Company's Statement of Financial Position when the Company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include trade and other receivables, cash and bank balances, are initially measured at their transaction price including transaction costs and are subsequently carried at their amortised cost using the effective interest method, less any provision for impairment, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.

Discounting is omitted where the effect of discounting is immaterial. The Company's cash and cash equivalents, trade and most other receivables due with the operating cycle fall into this category of financial instruments.

Impairment of financial assets

Financial assets are assessed for indicators of impairment at each reporting date. 

Financial assets are impaired when events, subsequent to their initial recognition, indicate the estimated future cash flows derived from the financial asset(s) have been adversely impacted. The impairment loss will be the difference between the current carrying amount and the present value of the future cash flows at the asset(s) original effective interest rate.

If there is a favourable change in relation to the events surrounding the impairment loss then the impairment can be reviewed for possible reversal. The reversal will not cause the current carrying amount to exceed the original carrying amount had the impairment not been recognised. The impairment reversal is recognised in the profit or loss.

- 6 -

 
 NI677902
30 September 2024
MY HEALTH DIGITAL LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2024

2.Accounting policies (continued)


2.12
Financial instruments (continued)

Financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after the deduction of all its liabilities.

Basic financial liabilities, which include trade and other payables, bank loans and other loans are initially measured at their transaction price after transaction costs. When this constitutes a financing transaction, whereby the debt instrument is measured at the present value of the future receipts discounted at a market rate of interest, discounting is omitted where the effect of discounting is immaterial.

Debt instruments are subsequently carried at their amortised cost using the effective interest rate method.

Trade payables are obligations to pay for goods and services that have been acquired in the ordinary course of business from suppliers. Trade payables are classified as current liabilities if the payment is due within one year. If not, they represent non-current liabilities. Trade payables are initially recognised at their transaction price and subsequently are measured at amortised cost using the effective interest method. Discounting is omitted where the effect of discounting is immaterial.

Derecognition of financial instruments

Derecognition of financial assets

Financial assets are derecognised when their contractual right to future cash flow expire, or are settled, or when the Company transfers the asset and substantially all the risks and rewards of ownership to another party. If significant risks and rewards of ownership are retained after the transfer to another party, then the Company will continue to recognise the value of the portion of the risks and rewards retained.

Derecognition of financial liabilities

Financial liabilities are derecognised when the Company's contractual obligations expire or are discharged or cancelled.

- 7 -

 
 NI677902
30 September 2024
MY HEALTH DIGITAL LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2024

3.


Judgments in applying accounting policies and key sources of estimation uncertainty

The directors do not believe there to be any critical judgments to have been made in the process of applying the Company's accounting policies that have had a significant effect on the amounts recognised in the statutory financial statements.
Tangible fixed assets
Tangible fixed assets are depreciated over their useful lives taking into account residual values, where appropriate. The actual lives of the assets and residual values are assessed annually and may vary depending on the number of factors. In re-assessing asset lives, factors such as technological innovation, product life cycles and maintenance programmes are taken into account. Residual value assessments consider issues such as future market conditions, the remaining life of the asset and projected disposal values.
Recoverability of debtors
The Company establishes a provision for debtors that are estimated not to be recoverable. When assessing recoverability, the directors have considered factors such as the ageing of debtors, past experience of recoverability, and the credit profile of individual or groups of customers.
Determining stock impairment
The Group includes a stock impairment for slow moving and obsolete stock. The directors assess the stock on a regular basis to ensure that stock is correctly valued at the lower of net realisable value and cost price. In assessing the net realisable value there is a certain amount of estimation required. The directors review historic sales and assess the likelihood of selling the item before making their impairment.


4.


Employees

The average monthly number of employees, including directors, during the year was 3 (2023 - 3).

- 8 -

 
 NI677902
30 September 2024
MY HEALTH DIGITAL LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2024

5.


Tangible fixed assets





L/Term Leasehold Property
Fixtures & fittings
Computer equipment
Total

£
£
£
£



Cost


At 1 October 2023
22,340
5,040
2,545
29,925



At 30 September 2024

22,340
5,040
2,545
29,925



Depreciation


At 1 October 2023
7,891
392
1,767
10,050


Charge for the year
4,468
1,008
778
6,254



At 30 September 2024

12,359
1,400
2,545
16,304



Net book value



At 30 September 2024
9,981
3,640
-
13,621



At 30 September 2023
14,449
4,648
778
19,875

- 9 -

 
 NI677902
30 September 2024
MY HEALTH DIGITAL LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2024

6.


Stocks

2024
2023
£
£

Finished goods and goods for resale
76,780
30,743



7.


Debtors

2024
2023
£
£


Trade debtors
47,759
28,654

Amounts owed by group undertakings
10,275
2,069

Other debtors
6,667
-

Prepayments and accrued income
5,551
4,899

70,252
35,622


Amounts owed by group undertakings are unsecured, interest free and repayable on demand. 


8.


Cash and cash equivalents

2024
2023
£
£

Cash at bank and in hand
33,347
4,204



9.


Creditors: Amounts falling due within one year

2024
2023
£
£

Trade creditors
14,481
12,761

Amounts owed to group undertakings
97,500
12,500

Corporation tax
13,517
4,330

Other creditors
-
33,542

Accruals and deferred income
10,740
18,625

136,238
81,758


Amounts owed to group undertakings are unsecured, interest free and repayable on demand. 

- 10 -

 
 NI677902
30 September 2024
MY HEALTH DIGITAL LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2024

10.


Deferred taxation




2024
2023


£

£






At beginning of year
(1,748)
(479)


Utilised in year
1,414
(1,269)



At end of year
(334)
(1,748)

The provision for deferred taxation is made up as follows:

2024
2023
£
£


Fixed asset timing differences
(334)
(1,748)


11.


Share capital

2024
2023
£
£
Allotted, called up and fully paid



200 (2023 - 200) Ordinary shares of £1.00 each
200
200

Ordinary shares hold full rights in respect of voting, participation and dividends.


12.


Reserves

Profit & loss account

This reserve represents the cumulative profit/(loss) of the Company.

13.


Commitments under operating leases

At 30 September 2024 the Company had future minimum lease payments due under non-cancellable operating leases for each of the following periods:

2024
2023
£
£


Not later than 1 year
34,196
6,751

Later than 1 year and not later than 5 years
48,444
-

82,640
6,751

- 11 -

 
 NI677902
30 September 2024
MY HEALTH DIGITAL LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2024

14.


Related party transactions

In accordance with Section 33 of FRS 102, transactions and balances with Group companies included within the consolidated financial statements of JCCO Healthcare Limited have not been disclosed within these financial statements. JCCO Healthcare Limited is the immediate controlling party and the consolidated financial statements are available from Companies House.


15.


Controlling party

The immediate controlling party is JCCO Healthcare Limited who is the only shareholder.
The directors do not deem there to be any ultimate controlling party.


16.


Auditor's information

The auditor's report on the financial statements for the year ended 30 September 2024 was unqualified.

The audit report was signed on 9 April 2025 by John Daly (Senior Statutory Auditor) on behalf of Forvis Mazars LLP.

 
- 12 -